News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–16
Matches
16
Sources here
12
Companies here
2
Search results Stored financial headlines

Active search

16 matching headlines

Ticker or company: LONAMain company stories
Clear
Latest

MarketBeat Earnings

Athira Pharma (NASDAQ:LONA) Announces Quarterly Earnings Results

Athira Pharma (NASDAQ:LONA) reported quarterly earnings of ($0.80) per share, significantly beating the consensus estimate of ($1.90). Following the announcement, shares rose 1.4% to $7.98. Analysts maintain a "Moderate Buy" rating with a $16 price target, and institutional investors hold 57.12% of the company's stock.

Main company 🇺🇸 United States
Read at MarketBeat
Sharemaestro market context Price below Trend Line 52 weeks +100.1% · Next-week setup negative 41.1% LONA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MarketBeat Earnings Main company 🇺🇸 United States

Athira Pharma, Inc. (NASDAQ:LONA) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Athira Pharma, Inc. (NASDAQ:LONA) has received a "Moderate Buy" consensus rating from analysts, with four out of six recommending a buy. The average 12-month price target is set at $16.00, significantly higher than its current share price of $7.68. Despite being a high-risk, clinical-stage …

LONA main company
Sharemaestro market context Price below Trend Line 52 weeks +100.1% · Next-week setup negative 41.1% LONA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context